ViroPharma (VPHM) Moves Higher Following Strong FY12 Outlook
Tweet
Share
E-mailGet Alerts VPHM Hot Sheet
Join SI Premium – FREE
ViroPharma (Nasdaq: VPHM) shares are moving 6.5 percent higher post-market Thursday, following better-than-expected numbers for its fiscal 2012 outlook. The company sees worldwide net product sales of $600 to $660 million, versus the consensus of $593.24 million. For more, click here.
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
